Wiser Advisor Group’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$22.3K Hold
102
0.03% 123
2025
Q4
$23.2K Buy
102
+1
+1% +$228 0.03% 127
2025
Q3
$23.4K Buy
+101
New +$20.6K 0.03% 129
2025
Q2
Sell
-99
Closed -$20.8K 41
2025
Q1
$20.8K Buy
99
+1
+1% +$194 0.03% 145
2024
Q4
$17.5K Buy
98
+1
+1% +$184 0.03% 153
2024
Q3
$19.2K Buy
97
+1
+1% +$187 0.03% 158
2024
Q2
$16.6K Buy
96
+1
+1% +$166 0.03% 164
2024
Q1
$17.4K Hold
95
0.03% 157
2023
Q4
$14.7K Buy
+95
New +$13.8K 0.02% 167

Other funds holding ABBV

Wiser Advisor Group's ABBV Position: Q1 2026 in Review

Wiser Advisor Group held its AbbVie (ABBV) position steady in Q1 2026 at 102 shares worth $22.3K. The position accounts for 0.03% of the portfolio, ranked #123.

Wiser Advisor Group first reported a position in ABBV in Q4 2023 and has held it in 9 quarters since. The position peaked at $23.4K in Q3 2025. 4,074 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Wiser Advisor Group held 102 shares of AbbVie worth $22.3K as of Q1 2026.
  • Wiser Advisor Group left its AbbVie share count unchanged in Q1 2026.
  • AbbVie made up 0.03% of Wiser Advisor Group's portfolio in Q1 2026, its #123 holding.
  • Wiser Advisor Group first reported a position in AbbVie in Q4 2023 and has held it in 9 quarters since.
  • Wiser Advisor Group's AbbVie position peaked at $23.4K in Q3 2025.
  • 4,074 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Wiser Advisor Group's 13F filing for Q1 2026, filed 22 Apr 2026.